TRINA EAGAL: Open Payments
NPI 1407203573 · STOCKTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 17 payments from 9 companies in 2025. Trend: 2023 $848 · 2024 $829 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $192 |
| Actelion Pharmaceuticals US, Inc. | 1 | $107 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $45 |
| United Therapeutics Corporation | 2 | $40 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| PFIZER INC. | 1 | $18 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
Products named: CARDIOMEMS, UPTRAVI, LifeVest, WINREVAIR, AMVUTTRA, ORENITRAM, Kerendia, VYNDAQEL.
Industry payments across CA — which companies pay providers there.
